問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

劉震鐘
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

1Cases

2021-10-01 - 2025-04-18

Phase III

Completed
An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials (CONNEX-X)
  • Condition/Disease

    schizophrenia

  • Test Drug

    BI 425809

Participate Sites
10Sites

Not yet recruiting9Sites

Recruiting1Sites